Selected research
Industry Research
Glucosamine Sulfate API Industry Research Report 2026
Market perspective
The global Glucosamine Sulfate API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Glucosamine Sulfate API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Glucosamine Sulfate API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Glucosamine Sulfate API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Glucosamine Sulfate API include Andhra Medi Pharma, Bioiberica, Panvo Organics, TSI, Fujian huakang pharmaceutical, Jiangsu Shuanglin Marine Biological Pharmaceutical, Shandong Runde Biotechnology, Yangzhou Rixing Bio-tech and Zhejiang Zhoushan Putuo Xinxing Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Glucosamine Sulfate API market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glucosamine Sulfate API Market by Company
Andhra Medi Pharma
Bioiberica
Panvo Organics
TSI
Fujian huakang pharmaceutical
Jiangsu Shuanglin Marine Biological Pharmaceutical
Shandong Runde Biotechnology
Yangzhou Rixing Bio-tech
Zhejiang Zhoushan Putuo Xinxing Pharmaceutical
Glucosamine Sulfate API Segment by Type
Glucosamine Sulfate Sodium Salt
Glucosamine Sulfate Potassium Salt
Glucosamine Sulfate API Segment by Application
Pharmaceutical
Health Products
Glucosamine Sulfate API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucosamine Sulfate API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucosamine Sulfate API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucosamine Sulfate API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glucosamine Sulfate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glucosamine Sulfate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glucosamine Sulfate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glucosamine Sulfate Sodium Salt
- Glucosamine Sulfate Potassium Salt
Applications
- Pharmaceutical
- Health Products
Companies covered
- Andhra Medi Pharma
- Bioiberica
- Panvo Organics
- TSI
- Fujian huakang pharmaceutical
- Jiangsu Shuanglin Marine Biological Pharmaceutical
- Shandong Runde Biotechnology
- Yangzhou Rixing Bio-tech
- Zhejiang Zhoushan Putuo Xinxing Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glucosamine Sulfate API Market Size (2021-2032)
- 2.2.2 Global Glucosamine Sulfate API Sales (2021-2032)
- 2.2.3 Global Glucosamine Sulfate API Market Average Price (2021-2032)
- 2.3 Glucosamine Sulfate API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Glucosamine Sulfate Sodium Salt
- 2.3.3 Glucosamine Sulfate Potassium Salt
- 2.4 Glucosamine Sulfate API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical
- 2.4.3 Health Products
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glucosamine Sulfate API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glucosamine Sulfate API Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Glucosamine Sulfate API Revenue of Manufacturers (2021-2026)
- 3.4 Global Glucosamine Sulfate API Average Price by Manufacturers (2021-2026)
- 3.5 Global Glucosamine Sulfate API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glucosamine Sulfate API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glucosamine Sulfate API, Product Type & Application
- 3.8 Global Manufacturers of Glucosamine Sulfate API, Established Date
- 3.9 Global Glucosamine Sulfate API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Andhra Medi Pharma
- 4.1.1 Andhra Medi Pharma Company Information
- 4.1.2 Andhra Medi Pharma Business Overview
- 4.1.3 Andhra Medi Pharma Glucosamine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Andhra Medi Pharma Glucosamine Sulfate API Product Portfolio
- 4.1.5 Andhra Medi Pharma Recent Developments
- 4.2 Bioiberica
- 4.2.1 Bioiberica Company Information
- 4.2.2 Bioiberica Business Overview
- 4.2.3 Bioiberica Glucosamine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bioiberica Glucosamine Sulfate API Product Portfolio
- 4.2.5 Bioiberica Recent Developments
- 4.3 Panvo Organics
- 4.3.1 Panvo Organics Company Information
- 4.3.2 Panvo Organics Business Overview
- 4.3.3 Panvo Organics Glucosamine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Panvo Organics Glucosamine Sulfate API Product Portfolio
- 4.3.5 Panvo Organics Recent Developments
- 4.4 TSI
- 4.4.1 TSI Company Information
- 4.4.2 TSI Business Overview
- 4.4.3 TSI Glucosamine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 TSI Glucosamine Sulfate API Product Portfolio
- 4.4.5 TSI Recent Developments
- 4.5 Fujian huakang pharmaceutical
- 4.5.1 Fujian huakang pharmaceutical Company Information
- 4.5.2 Fujian huakang pharmaceutical Business Overview
- 4.5.3 Fujian huakang pharmaceutical Glucosamine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Fujian huakang pharmaceutical Glucosamine Sulfate API Product Portfolio
- 4.5.5 Fujian huakang pharmaceutical Recent Developments
- 4.6 Jiangsu Shuanglin Marine Biological Pharmaceutical
- 4.6.1 Jiangsu Shuanglin Marine Biological Pharmaceutical Company Information
- 4.6.2 Jiangsu Shuanglin Marine Biological Pharmaceutical Business Overview
- 4.6.3 Jiangsu Shuanglin Marine Biological Pharmaceutical Glucosamine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jiangsu Shuanglin Marine Biological Pharmaceutical Glucosamine Sulfate API Product Portfolio
- 4.6.5 Jiangsu Shuanglin Marine Biological Pharmaceutical Recent Developments
- 4.7 Shandong Runde Biotechnology
- 4.7.1 Shandong Runde Biotechnology Company Information
- 4.7.2 Shandong Runde Biotechnology Business Overview
- 4.7.3 Shandong Runde Biotechnology Glucosamine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shandong Runde Biotechnology Glucosamine Sulfate API Product Portfolio
- 4.7.5 Shandong Runde Biotechnology Recent Developments
- 4.8 Yangzhou Rixing Bio-tech
- 4.8.1 Yangzhou Rixing Bio-tech Company Information
- 4.8.2 Yangzhou Rixing Bio-tech Business Overview
- 4.8.3 Yangzhou Rixing Bio-tech Glucosamine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Yangzhou Rixing Bio-tech Glucosamine Sulfate API Product Portfolio
- 4.8.5 Yangzhou Rixing Bio-tech Recent Developments
- 4.9 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical
- 4.9.1 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Company Information
- 4.9.2 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Business Overview
- 4.9.3 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Glucosamine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Glucosamine Sulfate API Product Portfolio
- 4.9.5 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Recent Developments
5 Global Glucosamine Sulfate API Market Scenario by Region
- 5.1 Global Glucosamine Sulfate API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glucosamine Sulfate API Sales by Region: 2021-2032
- 5.2.1 Global Glucosamine Sulfate API Sales by Region: 2021-2026
- 5.2.2 Global Glucosamine Sulfate API Sales by Region: 2027-2032
- 5.3 Global Glucosamine Sulfate API Revenue by Region: 2021-2032
- 5.3.1 Global Glucosamine Sulfate API Revenue by Region: 2021-2026
- 5.3.2 Global Glucosamine Sulfate API Revenue by Region: 2027-2032
- 5.4 North America Glucosamine Sulfate API Market Facts & Figures by Country
- 5.4.1 North America Glucosamine Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glucosamine Sulfate API Sales by Country (2021-2032)
- 5.4.3 North America Glucosamine Sulfate API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Glucosamine Sulfate API Market Facts & Figures by Country
- 5.5.1 Europe Glucosamine Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glucosamine Sulfate API Sales by Country (2021-2032)
- 5.5.3 Europe Glucosamine Sulfate API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Glucosamine Sulfate API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glucosamine Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glucosamine Sulfate API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glucosamine Sulfate API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glucosamine Sulfate API Market Facts & Figures by Country
- 5.7.1 South America Glucosamine Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glucosamine Sulfate API Sales by Country (2021-2032)
- 5.7.3 South America Glucosamine Sulfate API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Glucosamine Sulfate API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glucosamine Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glucosamine Sulfate API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glucosamine Sulfate API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Glucosamine Sulfate API Sales by Type (2021-2032)
- 6.1.1 Global Glucosamine Sulfate API Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Glucosamine Sulfate API Sales Market Share by Type (2021-2032)
- 6.2 Global Glucosamine Sulfate API Revenue by Type (2021-2032)
- 6.2.1 Global Glucosamine Sulfate API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glucosamine Sulfate API Revenue Market Share by Type (2021-2032)
- 6.3 Global Glucosamine Sulfate API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glucosamine Sulfate API Sales by Application (2021-2032)
- 7.1.1 Global Glucosamine Sulfate API Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Glucosamine Sulfate API Sales Market Share by Application (2021-2032)
- 7.2 Global Glucosamine Sulfate API Revenue by Application (2021-2032)
- 7.2.1 Global Glucosamine Sulfate API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glucosamine Sulfate API Revenue Market Share by Application (2021-2032)
- 7.3 Global Glucosamine Sulfate API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glucosamine Sulfate API Value Chain Analysis
- 8.1.1 Glucosamine Sulfate API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glucosamine Sulfate API Production Mode & Process
- 8.2 Glucosamine Sulfate API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glucosamine Sulfate API Distributors
- 8.2.3 Glucosamine Sulfate API Customers
9 Global Glucosamine Sulfate API Analyzing Market Dynamics
- 9.1 Glucosamine Sulfate API Industry Trends
- 9.2 Glucosamine Sulfate API Industry Drivers
- 9.3 Glucosamine Sulfate API Industry Opportunities and Challenges
- 9.4 Glucosamine Sulfate API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst